The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
US CDC Real-Time Reverse Transcription PCR Panel for Detection of Severe Acute Respiratory Syndrome Coronavirus 2
Open accessAbstract
O n December 31, 2019, an outbreak of an unex- plained acute respiratory disease, later designated coronavirus disease (COVID-19), was reported in Wuhan, China (1).On January 7, 2020, a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), previously known as 2019-nCoV, was identified as the causative agent of the outbreak (2).On January 10, 2020, a SARS-CoV-2 genome sequence was shared with the global scientific community through an online resource (3).The virus was genetically most closely related to SARS-CoV and SARS-related bat and civet coronaviruses within the family Betacoronavirus, subgenus Sarbecovirus (4,5).To support the potential public health emergency response to COVID-19, the Centers for Disease Control and Prevention (CDC) developed and validated a real-time reverse transcription PCR (rRT-PCR) panel based on this SARS-CoV-2 genome sequence (3).The panel targeted the nucleocapsid protein (N) gene of SARS-CoV-2.The rRT-PCR panel was validated under the Clinical Laboratory Improvement Amendments (https://www.cms.gov/Regulations-and-Guidance/Legislation/CLIA) for CDC use for diagnosis of SARS-CoV-2 from respiratory clinical specimens.On January 20, 2020, the CDC rRT-PCR panel confirmed an early case of COVID-19 in the United States (6).The US Food and Drug Administration issued an Emergency Use Authorization to enable emergency use of the CDC rRT-PCR panel as an in vitro diagnostic test for SARS-CoV-2 (https:// www.fda.gov/news-events/press-announcements/fda-takes-significant-step-coronavirus-responseefforts-issues-emergency-use-authorization-first).From January 18 through February 27, as part of the COVID-19 response, CDC tested 2,923 specimens from 998 persons for SARS-CoV-2.As of April 22, ≈2,400,000 confirmed COVID-19 cases and ≈169,000 associated deaths had been identified globally, including ≈770,000 cases and ≈37,000 deaths in the United States (7).We describe the design and validation of the CDC rRT-PCR panel and present comprehensive data on its performance with US CDC Real-Time Reverse Transcription PCR Panel for Detection of Severe Acute Respiratory Syndrome Coronavirus 2
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Lu, R., Zhao, X., Li, J., Niu, P., Yang, B., Wu, H., Wang, W., Song, H., Huang, B., Zhu, N., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30251-8 · Cited by 11,907
Self-citationVirological assessment of hospitalized patients with COVID-2019
Wölfel, R., Corman, V. M., Guggemos, W., Seilmaier, M., Zange, S., Müller, M. A., Niemeyer, D., Jones, T. C., Vollmar, P., Rothe, C., et al. (2020) · Nature · doi:10.1038/s41586-020-2196-x · Cited by 6,661
First case of 2019 novel coronavirus in the United States
Holshue, M. L., DeBolt, C., Lindquist, S., Lofy, K. H., Wiesman, J., Bruce, H., Spitters, C., Ericson, K., Wilkerson, S., Tural, A., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001191 · Cited by 6,030
Self-citationHamming, I., Timens, W., Bulthuis, M., Lely, A., Navis, G., & van Goor, H. (2004) · The Journal of Pathology · doi:10.1002/path.1570 · Cited by 5,676
SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients
Zou, L., Ruan, F., Huang, M., Liang, L., Huang, H., Hong, Z., Yu, J., Kang, M., Song, Y., Xia, J., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2001737 · Cited by 4,810
Chan, J. F.-W., Kok, K.-H., Zhu, Z., Chu, H., To, K. K.-W., Yuan, S., & Yuen, K.-Y. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1719902 · Cited by 3,059
Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia
Chu, D. K. W., Pan, Y., Cheng, S. M. S., Hui, K. P. Y., Krishnan, P., Liu, Y., Ng, D. Y. M., Wan, C. K. C., Yang, P., Wang, Q., et al. (2020) · Clinical Chemistry · doi:10.1093/clinchem/hvaa029 · Cited by 1,278
Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with Coronavirus Disease, United States
Harcourt, J., Tamin, A., Lu, X., Kamili, S., Sakthivel, S. K., Murray, J., Queen, K., Tao, Y., Paden, C. R., Zhang, J., et al. (2020) · Emerging Infectious Diseases · doi:10.3201/eid2606.200516 · Cited by 542
Self-citationNalla, A. K., Casto, A. M., Huang, M.-L. W., Perchetti, G. A., Sampoleo, R., Shrestha, L., Wei, Y., Zhu, H., Jerome, K. R., & Greninger, A. L. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.00557-20 · Cited by 434
The COVID-19 Investigation Team (2020) · Nature Medicine · doi:10.1038/s41591-020-0877-5 · Cited by 405
Real-Time Reverse Transcription–Polymerase Chain Reaction Assay for SARS-associated Coronavirus
Emery, S. L., Erdman, D. D., Bowen, M. D., Newton, B. R., Winchell, J. M., Meyer, R. F., Tong, S., Cook, B. T., Holloway, B. P., McCaustland, K. A., et al. (2004) · Emerging Infectious Diseases · doi:10.3201/eid1002.030759 · Cited by 353
Transmission dynamics and evolutionary history of 2019‐nCoV
Li, X., Wang, W., Zhao, X., Zai, J., Zhao, Q., Li, Y., & Chaillon, A. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25701 · Cited by 321
Detection of SARS Coronavirus in Patients with Suspected SARS
Chan, K. H., Poon, L. L. L. M., Cheng, V. C. C., Guan, Y., Hung, I. F. N., Kong, J., Yam, L. Y. C., Seto, W. H., Yuen, K. Y., & Peiris, J. S. M. (2004) · Emerging Infectious Diseases · doi:10.3201/eid1002.030610 · Cited by 314
Detection of SARS Coronavirus in Plasma by Real-Time RT-PCR
Grant, P. R., Garson, J. A., Tedder, R. S., Chan, P. K. S., Tam, J. S., & Sung, J. J. �. (2003) · New England Journal of Medicine · doi:10.1056/nejm200312183492522 · Cited by 126
Al-Abdely, H. M., Midgley, C. M., Alkhamis, A. M., Abedi, G. R., Lu, X., Binder, A. M., Alanazi, K. H., Tamin, A., Banjar, W. M., Lester, S. N., et al. (2019) · Emerging infectious diseases · doi:10.3201/eid2504.181595 · Cited by 82
Self-citationIdentification of a Coronavirus Transcription Enhancer
Moreno, J. L., Zúñiga, S., Enjuanes, L., & Sola, I. (2008) · Journal of Virology · doi:10.1128/jvi.02622-07 · Cited by 73
Cited by
Applying principles of behaviour change to reduce SARS-CoV-2 transmission
West, R., Michie, S., Rubin, G. J., & Amlôt, R. (2020) · Nature Human Behaviour · doi:10.1038/s41562-020-0887-9 · Cited by 658
COVID-19 surveillance in Southeastern Virginia using wastewater-based epidemiology
Gonzalez, R., Curtis, K., Bivins, A., Bibby, K., Weir, M. H., Yetka, K., Thompson, H., Keeling, D., Mitchell, J., & Gonzalez, D. (2020) · Water Research · doi:10.1016/j.watres.2020.116296 · Cited by 435
Nucleocapsid protein of SARS-CoV-2 phase separates into RNA-rich polymerase-containing condensates
Savastano, A., Ibáñez de Opakua, A., Rankovic, M., & Zweckstetter, M. (2020) · Nature Communications · doi:10.1038/s41467-020-19843-1 · Cited by 417
Rapid electrochemical detection of coronavirus SARS-CoV-2
Chaibun, T., Puenpa, J., Ngamdee, T., Boonapatcharoen, N., Athamanolap, P., O’Mullane, A. P., Vongpunsawad, S., Poovorawan, Y., Lee, S. Y., & Lertanantawong, B. (2021) · Nature Communications · doi:10.1038/s41467-021-21121-7 · Cited by 405
Pace, R. M., Williams, J. E., Järvinen, K. M., Belfort, M. B., Pace, C. D. W., Lackey, K. A., Gogel, A. C., Nguyen-Contant, P., Kanagaiah, P., Fitzgerald, T., et al. (2021) · mBio · doi:10.1128/mbio.03192-20 · Cited by 315
Metadata
- Authors
- Lu, X., Wang, L., Sakthivel, S. K., Whitaker, B., Murray, J., Kamili, S., Lynch, B., Malapati, L., Burke, S. A., Harcourt, J., Tamin, A., Thornburg, N. J., Villanueva, J. M., & Lindstrom, S.
- Venue
- Emerging Infectious Diseases
- Published
- 2020-08
- Volume
- 26
- Issue
- 8
- Pages
- 1654-1665
- ISSN
- 1080-6040 (ISSN-L)
- 1080-6059
- OpenAlex
- W3024623392
- Cited by
- 676
- References
- 18
- FWCI
- 13.97
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.